Article Information
History
- July 29, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Matthew C. Hyman, MD, PhD1,*,
- Michael G. Levin, MD1,2,*,
- Dipender Gill, BMBCh, PhD3,4,5,6,7,
- Venexia M. Walker, PhD8,9,11,
- Marios K. Georgakis, MD, PhD10,
- Neil Davies, PhD8,
- Francis E. Marchlinski, MD1 and
- Scott M. Damrauer, MD2,11,†
- 1Division of Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
- 2Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
- 3Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, United Kingdom
- 4Centre for Pharmacology and Therapeutics, Department of Medicine, Hammersmith Campus, Imperial College London, London, UK
- 5Department of Genetics, Novo Nordisk Research Centre Oxford, Old Road Campus, Oxford, UK
- 6Clinical Pharmacology and Therapeutics Section, Institute of Medical and Biomedical Education and Institute for Infection and Immunity, St George’s, University of London, London, UK
- 7Clinical Pharmacology Group, Pharmacy and Medicines Directorate, St George’s University Hospitals NHS Foundation Trust, London, UK
- 8Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom
- 9Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, United Kingdom
- 10Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig- Maximilians-University LMU, Munich, Germany
- 11Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
- ↵†Corresponding Author:
Scott M. Damrauer, University of Pennsylvania, 2400 Spruce Street, Silverstein 4, Philadelphia, PA 19104, Phone: 215-615-1698damrauer{at}upenn.edu